Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

GM1 Gangliosidosis-1 History


Dr. Landing gave the first definitive description of Gangliosidosis-1 (GM-1) in 1964, which had variously been called "Hurler variant," "pseudo-Hurler disease," and "Tay-Sachs with visceral involvement."

Dr. Caffey likely gave the earliest description of GM-1 in 1951 discussing prenatal onset of Hunter-Hurler disease.